Operating
Increase (Decrease) in Other Current Assets
West Pharmaceutical Services Increase (Decrease) in Other Current Assets remained flat by 0.0% to -$2.43M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 267.2%, from $1.45M to -$2.43M. Over 4 years (FY 2021 to FY 2025), Increase (Decrease) in Other Current Assets shows a downward trend with a 7.4% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
First reportedQ1 2013
Last reportedQ4 2025Feb 17, 2026
Metric ID:
operating_increase_decrease_in_other_current_assetsHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $7.3M | -$18.5M | $21.3M | $5.8M | -$9.7M |
| YoY Change | — | -353.4% | +215.1% | -72.8% | -267.2% |
Range-$18.5M – $21.3M
CAGR+7.4%
Avg YoY Growth-119.6%
Median YoY Growth-170.0%
Current Streak2 years decline
Increase (Decrease) in Other Current Assets at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's increase (decrease) in other current assets?
- West Pharmaceutical Services (WST) reported increase (decrease) in other current assets of -$2.43M in Q4 2025.
- How has West Pharmaceutical Services's increase (decrease) in other current assets changed year-over-year?
- West Pharmaceutical Services's increase (decrease) in other current assets decreased by 267.2% year-over-year, from $1.45M to -$2.43M.
- What is the long-term trend for West Pharmaceutical Services's increase (decrease) in other current assets?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's increase (decrease) in other current assets has grown at a 7.4% compound annual growth rate (CAGR), from $7.3M to -$9.7M.